Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry

Gaspar Aspas Requena, Eliana Aguiar, Joana Brioso, Rosa Ayala, Josefina Serrano López, Jorge Labrador Gómez, Eduardo Rodríguez-Arbolí, Mar Tormo, Teresa Bernal del Castillo, Olga Arce Fernández, Francisco Ibáñez Alís, Manuel Pérez Encinas, Carlos Rodríguez-Medina, Ágata Almela Gallego, Olga Salamero, José Luis López Lorenzo, Claudia Lucía Sossa Melo, María José Mela Osorio, Juan Miguel Bergua Burgues, Susana Vives, Aitor Abuín, María Dolores Madrigal, Cristina Gil, Alberto Giménez Conca, Marta Valero Núñez, José Mário Mariz, María-Ángeles Foncillas, Silvina Palmer, Marcela Espinoza, Bernardo Javier González González, María Carmen García Garay, Lara María Gómez García, Daniel García Belmonte, Ana Alfonso Piérola, Diana Marcela Cuervo Lozada, Carlos Varón, Ana Lisa Basquiera, Miguel López, María Lourdes Amador Barciela, María Solé Rodríguez, María Marta Rivas, Sandra Casal Marini, Alicia Roldán Pérez, María-Belén Vidriales, Raimundo García Boyero, Isabel Recio, María Luz Amigo, Kenny Gálvez, Pilar Lloret Madrid, Pau Montesinos

Open source

DOI
10.1038/s41375-026-03154-3
Published
2026-10-06
Container
Leukemia
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41375-026-03154-3,
  title = {Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry},
  author = {Gaspar Aspas Requena and Eliana Aguiar and Joana Brioso and Rosa Ayala and Josefina Serrano López and Jorge Labrador Gómez and Eduardo Rodríguez-Arbolí and Mar Tormo and Teresa Bernal del Castillo and Olga Arce Fernández and Francisco Ibáñez Alís and Manuel Pérez Encinas and Carlos Rodríguez-Medina and Ágata Almela Gallego and Olga Salamero and José Luis López Lorenzo and Claudia Lucía Sossa Melo and María José Mela Osorio and Juan Miguel Bergua Burgues and Susana Vives and Aitor Abuín and María Dolores Madrigal and Cristina Gil and Alberto Giménez Conca and Marta Valero Núñez and José Mário Mariz and María-Ángeles Foncillas and Silvina Palmer and Marcela Espinoza and Bernardo Javier González González and María Carmen García Garay and Lara María Gómez García and Daniel García Belmonte and Ana Alfonso Piérola and Diana Marcela Cuervo Lozada and Carlos Varón and Ana Lisa Basquiera and Miguel López and María Lourdes Amador Barciela and María Solé Rodríguez and María Marta Rivas and Sandra Casal Marini and Alicia Roldán Pérez and María-Belén Vidriales and Raimundo García Boyero and Isabel Recio and María Luz Amigo and Kenny Gálvez and Pilar Lloret Madrid and Pau Montesinos},
  year = {2026},
  journal = {Leukemia},
  doi = {10.1038/s41375-026-03154-3},
  url = {https://doi.org/10.1038/s41375-026-03154-3}
}

RIS

TY  - JOUR
TI  - Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry
AU  - Gaspar Aspas Requena
AU  - Eliana Aguiar
AU  - Joana Brioso
AU  - Rosa Ayala
AU  - Josefina Serrano López
AU  - Jorge Labrador Gómez
AU  - Eduardo Rodríguez-Arbolí
AU  - Mar Tormo
AU  - Teresa Bernal del Castillo
AU  - Olga Arce Fernández
AU  - Francisco Ibáñez Alís
AU  - Manuel Pérez Encinas
AU  - Carlos Rodríguez-Medina
AU  - Ágata Almela Gallego
AU  - Olga Salamero
AU  - José Luis López Lorenzo
AU  - Claudia Lucía Sossa Melo
AU  - María José Mela Osorio
AU  - Juan Miguel Bergua Burgues
AU  - Susana Vives
AU  - Aitor Abuín
AU  - María Dolores Madrigal
AU  - Cristina Gil
AU  - Alberto Giménez Conca
AU  - Marta Valero Núñez
AU  - José Mário Mariz
AU  - María-Ángeles Foncillas
AU  - Silvina Palmer
AU  - Marcela Espinoza
AU  - Bernardo Javier González González
AU  - María Carmen García Garay
AU  - Lara María Gómez García
AU  - Daniel García Belmonte
AU  - Ana Alfonso Piérola
AU  - Diana Marcela Cuervo Lozada
AU  - Carlos Varón
AU  - Ana Lisa Basquiera
AU  - Miguel López
AU  - María Lourdes Amador Barciela
AU  - María Solé Rodríguez
AU  - María Marta Rivas
AU  - Sandra Casal Marini
AU  - Alicia Roldán Pérez
AU  - María-Belén Vidriales
AU  - Raimundo García Boyero
AU  - Isabel Recio
AU  - María Luz Amigo
AU  - Kenny Gálvez
AU  - Pilar Lloret Madrid
AU  - Pau Montesinos
PY  - 2026
JO  - Leukemia
DO  - 10.1038/s41375-026-03154-3
UR  - https://doi.org/10.1038/s41375-026-03154-3
ER  -

APA

Requena, G. A., Aguiar, E., Brioso, J., Ayala, R., López, J. S., Gómez, J. L., Rodríguez-Arbolí, E., Tormo, M., Castillo, T. B. D., Fernández, O. A., Alís, F. I., Encinas, M. P., Rodríguez-Medina, C., Gallego, Á. A., Salamero, O., Lorenzo, J. L. L., Melo, C. L. S., Osorio, M. J. M., Burgues, J. M. B., Vives, S., Abuín, A., Madrigal, M. D., Gil, C., Conca, A. G., Núñez, M. V., Mariz, J. M., Foncillas, M., Palmer, S., Espinoza, M., González, B. J. G., Garay, M. C. G., García, L. M. G., Belmonte, D. G., Piérola, A. A., Lozada, D. M. C., Varón, C., Basquiera, A. L., López, M., Barciela, M. L. A., Rodríguez, M. S., Rivas, M. M., Marini, S. C., Pérez, A. R., Vidriales, M., Boyero, R. G., Recio, I., Amigo, M. L., Gálvez, K., Madrid, P. L., & Montesinos, P. (2026). Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry. Leukemia. https://doi.org/10.1038/s41375-026-03154-3

Source records